You have 9 free searches left this month | for more free features.

Pneumococcal vaccines

Showing 1 - 25 of 3,025

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pneumococcal Vaccines, Immunization Coverage Trial (Enhanced reminders, Standard CANImmunize notifications)

Not yet recruiting
  • Pneumococcal Vaccines
  • Immunization Coverage
  • Enhanced reminders
  • Standard CANImmunize notifications
  • (no location specified)
Aug 14, 2023

Pneumococcal Vaccines Trial (12-Valent Pneumococcal Conjugate Vaccine)

Not yet recruiting
  • Pneumococcal Vaccines
  • 12-Valent Pneumococcal Conjugate Vaccine
  • (no location specified)
Jan 31, 2023

Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)

Not yet recruiting
  • Pneumococcal Vaccines
  • IVT PCV-25 Formulation A
  • +3 more
  • Vancouver, British Columbia, Canada
  • +3 more
Oct 10, 2023

Pneumonia, Aging Trial in Farmington (Pneumococcal 13valent Conj Vaccine Diphtheria CRM197 Protein, Pneumococcal Vaccine

Completed
  • Pneumonia
  • Aging
  • Pneumococcal 13valent Conj Vaccine Diphtheria CRM197 Protein
  • Pneumococcal Vaccine Polyvalent
  • Farmington, Connecticut
    UConn Center On Aging
Nov 8, 2021

Pneumococcal Infections, HIV Trial (PPV-23 Vaccine, PCV-13 Vaccine, Placebo Vaccine)

Withdrawn
  • Pneumococcal Infections
  • HIV Infections
  • PPV-23 Vaccine
  • +2 more
  • (no location specified)
Oct 28, 2021

Pneumococcal Carriage Trial in Maradi (PCV10 full dose, PCV10 fractional dose)

Recruiting
  • Pneumococcal Carriage
  • PCV10 full dose
  • PCV10 fractional dose
  • Maradi, Niger
    Epicentre
May 31, 2022

Pneumococcal Vaccines Trial (IVT PCV-25, PCV 20, PCV 13)

Not yet recruiting
  • Pneumococcal Vaccines
  • IVT PCV-25
  • +2 more
  • (no location specified)
Sep 13, 2022

Safety, Immunogenicity, Vaccine, COVID-19 Vaccines Trial in Beijing (Vaccine)

Recruiting
  • Safety
  • +4 more
  • Vaccine
  • Beijing, China
  • +2 more
Mar 24, 2022

Asthma Trial in Rochester (PCV13, PPSV23)

Completed
  • Asthma
  • PCV13
  • PPSV23
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 7, 2021

Pneumococcal Vaccines Trial in United States (24 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate

Active, not recruiting
  • Pneumococcal Vaccines
  • 24 valent pneumococcal conjugate vaccine
  • 20 valent pneumococcal conjugate vaccine
  • Hollywood, Florida
  • +12 more
Jul 25, 2022

Pneumococcal Infection, Streptococcus Pneumoniae Infection, Invasive Pneumococcal Disease, Protection Against Trial in Kilifi

Active, not recruiting
  • Pneumococcal Infection
  • +2 more
  • PCV10
  • PCV13
  • Kilifi, Kenya
    KEMRI Wellcome Trust Research Programme
Feb 23, 2022

Pneumococcal Vaccines Trial in United States (31 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate

Recruiting
  • Pneumococcal Vaccines
  • 31 valent pneumococcal conjugate vaccine
  • 20 valent pneumococcal conjugate vaccine
  • Mobile, Alabama
  • +24 more
Nov 20, 2023

Pneumococcal Disease, Invasive Trial in Denpasar (Walvax PCV13-TT, Pfizer PCV13)

Not yet recruiting
  • Pneumococcal Disease, Invasive
  • Walvax PCV13-TT
  • Pfizer PCV13
  • Denpasar, Bali, Indonesia
    Departemen Ilmu Kesehatan Anak FK Unud
Jun 28, 2023

Pneumococcal Vaccines Trial in United States (0.5 ml dose of 1.1 mcg VAX-24, 0.5 ml dose of PCV15, 0.5 ml dose of 2.2 mcg

Recruiting
  • Pneumococcal Vaccines
  • 0.5 ml dose of 1.1 mcg VAX-24
  • +3 more
  • Jonesboro, Arkansas
  • +25 more
May 4, 2023

Fever After Vaccination, Fever, Seizures Fever Trial in United States (Pfizer-BioNTech COVID-19 Vaccine, Routine Childhood

Not yet recruiting
  • Fever After Vaccination
  • +2 more
  • Pfizer-BioNTech COVID-19 Vaccine
  • Routine Childhood Vaccinations
  • Oakland, California
  • +4 more
Sep 8, 2023

Pneumococcal Vaccines Trial in Ho Chi Minh City (PCV10, PCV13)

Active, not recruiting
  • Pneumococcal Vaccines
  • PCV10
  • PCV13
  • Ho Chi Minh City, Vietnam
    Pasteur Institute of Ho Chi Minh City
May 20, 2021

Pneumococcal Vaccines Trial in United States (24-Valent Pneumococcal Conjugate Vaccine, Pneumococcal 20-valent Conjugate

Recruiting
  • Pneumococcal Vaccines
  • 24-Valent Pneumococcal Conjugate Vaccine
  • Pneumococcal 20-valent Conjugate Vaccine
  • Birmingham, Alabama
  • +20 more
Jul 25, 2022

Apnea, Apnea Neonatal, Prematurity Trial in United States (PCV13, DTaP, HBV)

Completed
  • Apnea
  • +2 more
  • PCV13
  • +4 more
  • Atlanta, Georgia
  • +3 more
Dec 19, 2022

Meningococcal Infections Trial in Worldwide (MenACYW conjugate vaccine, Meningococcal group A, C, W-135, and Y conjugate

Active, not recruiting
  • Meningococcal Infections
  • MenACYW conjugate vaccine
  • +5 more
  • Chlumec Nad Cidlinou, Czechia
  • +30 more
Jan 4, 2023

Pneumococcal Vaccines Among Children and Elderly Adults.

Unknown status
  • Pneumococcal Vaccine Adverse Reaction
  • 10 or 13-valent pneumococcal conjugate vaccine
  • +2 more
  • Suwon, Gyeonggi-do, Korea, Republic of
    Sungkyunkwan University
Sep 9, 2020

Infectious Diseases Trial in Oxford (DTaP/IPV/Hib vaccine, 13 valent Pneumococcal Conjugate Vaccine, Rotavirus vaccine)

Completed
  • Infectious Diseases
  • DTaP/IPV/Hib vaccine
  • +5 more
  • Oxford, Oxfordshire, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine
Sep 17, 2021

Infections, Streptococcal, Streptococcus Pneumoniae Vaccines Trial in Cuernavaca, Monterrey, Mexico (Synflorix (3-Dose),

Completed
  • Infections, Streptococcal
  • Streptococcus Pneumoniae Vaccines
  • Synflorix (3-Dose)
  • +4 more
  • Cuernavaca, Morelos, Mexico
  • +2 more
Feb 8, 2021

Influenza, Human, Pneumonia, Pneumococcal, Covid19 Trial in Chengdu, Shanghai, Taiyuan (COVAX+IIV4; COVAX+PPV23, COVAX only (1st

Completed
  • Influenza, Human
  • +2 more
  • COVAX+IIV4; COVAX+PPV23
  • +2 more
  • Chengdu, China
  • +2 more
Oct 12, 2021

National Bacterial Meningitis Study

Recruiting
  • Meningitis
  • +7 more
  • observational study
  • Créteil, France
    ACTIV
Mar 18, 2021

Influenza, Human, Pneumonia, Pneumococcal, COVID-19 Pneumonia Trial in Guangzhou, Zhengzhou, Wuhan (COVAX+PPV23;COVAX+IIV4,

Active, not recruiting
  • Influenza, Human
  • +2 more
  • COVAX+PPV23;COVAX+IIV4
  • +2 more
  • Guangzhou, Guangdong, China
  • +2 more
Oct 5, 2021